CES 2024, themed “AI in Everything,” has prompted various industries to explore interdisciplinary integration, with the AI medical sector serving as a prominent example. Moderna, a pharmaceutical tech giant, has emerged as a frontrunner in leveraging AI for drug development. The company’s CIO, Brad Miller, highlighted Moderna’s groundbreaking use of generative AI in expediting the development of their COVID-19 vaccine within an astonishing 42 days. Miller emphasized the transformative potential of AI in revolutionizing traditional approaches to drug development and clinical trials, streamlining processes, reducing costs, and enhancing adaptability to global health challenges. Moderna’s presence at CES sparked curiosity, with Miller clarifying that despite being a healthcare company, Moderna operates more like a digital IT company, continuously innovating through the integration of AI, data, and digital capabilities.

Moderna’s breakthrough in AI-driven drug development represents a paradigm shift in the healthcare industry. The company utilizes AI to synthesize extensive datasets, generate code through data analysis, and produce reliable reports on immunogenicity and toxicity. This not only expedites decision-making in patient care but also sets the stage for a consumer-centric shift in personalized healthcare. Miller introduced “M Chat,” an internal platform leveraging generative AI, to centralize data across drug development, clinical research, manufacturing processes, regulatory affairs, and commercialization phases. Miller envisions generative AI as a conversational engine that encourages individuals to rethink concepts, fostering innovation. With over 70% of Moderna employees currently using M Chat, the company exemplifies the potential of AI to transform the landscape of healthcare and drug development.

Read more: https://www.digitimes.com/news/a20240125PD220/moderna-ai-healthcare-ces-2024-smart-medical.html?dt_ref=topic

#aiineverything #modernamedical #generativeai #healthtech #ces2024 #digitalinnovation #personalizedhealthcare #mchat #innovationinhealth #clinicaldataanalytics